Saquinavir Inhibits the malaria parasite's chloroquine resistance transporter
Download (873.41 kB)
Martin, Rowena; Butterworth, Alice S.; Gardiner, Donald L.; Kirk, Kiaran; McCarthy, James S.; Skinner-Adams, Tina S.
The antiretroviral protease inhibitors (APIs) ritonavir, saquinavir, and lopinavir, used to treat HIV infection, inhibit the growth of Plasmodium falciparum at clinically relevant concentrations. Moreover, it has been reported that these APIs potentiate the activity of chloroquine (CQ) against this parasite in vitro. The mechanism underlying this effect is not understood, but the degree of chemosensitization varies between the different APIs and, with the exception of ritonavir, appears to be...[Show more]
|Collections||ANU Research Publications|
|Source:||Antimicrobial Agents and Chemotherapy|
|Access Rights:||Open Access|
|01_Martin_Saquinavir_Inhibits_the_2012.pdf||873.41 kB||Adobe PDF|
Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.
Updated: 17 November 2022/ Responsible Officer: University Librarian/ Page Contact: Library Systems & Web Coordinator